{"transactions":[{"id":686587,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2026-08-14T21:12:22.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":29849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":29849},"source":{"system":"sec-edgar","filing":"0001539937-26-000012","document":"wk-form4_1786741940.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000012/wk-form4_1786741940.xml","form_type":"4"}},{"id":686586,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-08-14T21:12:22.000Z","date":"2026-08-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":12642,"price":46.57,"value":588737.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":1258351,"source":{"system":"sec-edgar","filing":"0001539937-26-000012","document":"wk-form4_1786741940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000012/wk-form4_1786741940.xml","form_type":"4"}},{"id":686585,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-08-14T21:12:22.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":29849,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1270993,"source":{"system":"sec-edgar","filing":"0001539937-26-000012","document":"wk-form4_1786741940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000012/wk-form4_1786741940.xml","form_type":"4"}},{"id":687004,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2026-08-14T21:11:50.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001836067-26-000010","document":"wk-form4_1786741908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000010/wk-form4_1786741908.xml","form_type":"4"}},{"id":687003,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-14T21:11:50.000Z","date":"2026-08-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":363,"price":46.57,"value":16904.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":13979,"source":{"system":"sec-edgar","filing":"0001836067-26-000010","document":"wk-form4_1786741908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000010/wk-form4_1786741908.xml","form_type":"4"}},{"id":687002,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-14T21:11:50.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":14342,"source":{"system":"sec-edgar","filing":"0001836067-26-000010","document":"wk-form4_1786741908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000010/wk-form4_1786741908.xml","form_type":"4"}},{"id":686584,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Performance Share Unit","published_at":"2026-08-14T21:11:16.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001539215-26-000012","document":"wk-form4_1786741874.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000012/wk-form4_1786741874.xml","form_type":"4"}},{"id":686583,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-08-14T21:11:16.000Z","date":"2026-08-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1158,"price":46.57,"value":53928.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":18637,"source":{"system":"sec-edgar","filing":"0001539215-26-000012","document":"wk-form4_1786741874.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000012/wk-form4_1786741874.xml","form_type":"4"}},{"id":686582,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-08-14T21:11:16.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":19795,"source":{"system":"sec-edgar","filing":"0001539215-26-000012","document":"wk-form4_1786741874.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000012/wk-form4_1786741874.xml","form_type":"4"}},{"id":686987,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Performance Share Unit","published_at":"2026-08-14T21:10:26.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":1650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1650},"source":{"system":"sec-edgar","filing":"0001804567-26-000014","document":"wk-form4_1786741823.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000014/wk-form4_1786741823.xml","form_type":"4"}},{"id":686986,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-08-14T21:10:26.000Z","date":"2026-08-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":797,"price":46.57,"value":37116.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":19544,"source":{"system":"sec-edgar","filing":"0001804567-26-000014","document":"wk-form4_1786741823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000014/wk-form4_1786741823.xml","form_type":"4"}},{"id":686985,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-08-14T21:10:26.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":1650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":20341,"source":{"system":"sec-edgar","filing":"0001804567-26-000014","document":"wk-form4_1786741823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000014/wk-form4_1786741823.xml","form_type":"4"}},{"id":686617,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2026-08-14T21:09:36.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001194020-26-000015","document":"wk-form4_1786741773.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000015/wk-form4_1786741773.xml","form_type":"4"}},{"id":686616,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-08-14T21:09:36.000Z","date":"2026-08-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":604,"price":46.57,"value":28128.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":9129,"source":{"system":"sec-edgar","filing":"0001194020-26-000015","document":"wk-form4_1786741773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000015/wk-form4_1786741773.xml","form_type":"4"}},{"id":686615,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-08-14T21:09:36.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":9733,"source":{"system":"sec-edgar","filing":"0001194020-26-000015","document":"wk-form4_1786741773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000015/wk-form4_1786741773.xml","form_type":"4"}},{"id":699771,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2026-07-31T21:06:38.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":29849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":29849,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":29849},"source":{"system":"sec-edgar","filing":"0001539937-26-000010","document":"wk-form4_1785531995.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000010/wk-form4_1785531995.xml","form_type":"4"}},{"id":699866,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2026-07-31T21:05:56.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":1250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001194020-26-000013","document":"wk-form4_1785531954.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000013/wk-form4_1785531954.xml","form_type":"4"}},{"id":700012,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Performance Share Unit","published_at":"2026-07-31T21:05:11.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":1650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":1650,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1650},"source":{"system":"sec-edgar","filing":"0001804567-26-000012","document":"wk-form4_1785531908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000012/wk-form4_1785531908.xml","form_type":"4"}},{"id":699769,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Performance Share Unit","published_at":"2026-07-31T21:04:39.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":2500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001539215-26-000010","document":"wk-form4_1785531875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000010/wk-form4_1785531875.xml","form_type":"4"}},{"id":700023,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2026-07-31T21:04:03.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001836067-26-000008","document":"wk-form4_1785531841.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000008/wk-form4_1785531841.xml","form_type":"4"}},{"id":834683,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-18","kind":"exercise","planned":true,"acquired":false,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option vested in four equal annual installments beginning on February 14, 2019."}],"balance_after":0,"derivative":{"exercise_price":39.4,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834682,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-17","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The option vests in four equal annual installments beginning on February 23, 2024."}],"balance_after":5000,"derivative":{"exercise_price":38.6,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834681,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-17","kind":"exercise","planned":true,"acquired":false,"shares":12250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vested in four equal annual installments beginning on February 22, 2020."}],"balance_after":0,"derivative":{"exercise_price":36.75,"expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":12250},"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834680,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-17","kind":"exercise","planned":true,"acquired":false,"shares":22750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option vested in four equal annual installments beginning on February 14, 2019."}],"balance_after":7250,"derivative":{"exercise_price":39.4,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":22750},"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834679,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option vests in four equal annual installments beginning on February 22, 2025."}],"balance_after":15000,"derivative":{"exercise_price":27.94,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834678,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vests in four equal annual installments beginning on February 22, 2023."}],"balance_after":0,"derivative":{"exercise_price":32.2,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834677,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":false,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vested in four equal annual installments beginning on February 19, 2022."}],"balance_after":0,"derivative":{"exercise_price":29.61,"expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834676,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":false,"shares":22750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vested in four equal annual installments beginning on February 22, 2020."}],"balance_after":12250,"derivative":{"exercise_price":36.75,"expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":22750},"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834675,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":412,"price":50.48,"value":20797.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."}],"balance_after":17044,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834674,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":6838,"price":49.55,"value":338822.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.40 to $49.99. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":17456,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834673,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-18","kind":"exercise","planned":true,"acquired":true,"shares":7250,"price":39.4,"value":285650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."}],"balance_after":24294,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834672,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":22290,"price":50.73,"value":1130771.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.40 to $51.15. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":17044,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834671,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":27710,"price":49.95,"value":1384114.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.40 to $50.39. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":39334,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834670,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-17","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":38.6,"value":579000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."}],"balance_after":67044,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834669,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-17","kind":"exercise","planned":true,"acquired":true,"shares":12250,"price":36.75,"value":450187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."}],"balance_after":52044,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834668,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-17","kind":"exercise","planned":true,"acquired":true,"shares":22750,"price":39.4,"value":896350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."}],"balance_after":39794,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834667,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":15886,"price":50.49,"value":802084.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.35 to $50.77. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":17044,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834666,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":34114,"price":50.18,"value":1711840.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.34 to $50.34. The Reporting Person undertakes to provide to\nSupernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold\nat each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":32930,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834665,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":27.94,"value":139700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."}],"balance_after":67044,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834664,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":32.2,"value":579600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."}],"balance_after":62044,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834663,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":true,"shares":4250,"price":29.61,"value":125842.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."}],"balance_after":44044,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":834662,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-03-18T21:18:35.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":true,"shares":22750,"price":36.75,"value":836062.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."}],"balance_after":39794,"source":{"system":"sec-edgar","filing":"0001539215-26-000008","document":"wk-form4_1773868712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000008/wk-form4_1773868712.xml","form_type":"4"}},{"id":841303,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-16T20:08:19.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":120,"price":51.75,"value":6210.0,"ownership":{"direct":false,"nature":"By the KBT Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."}],"balance_after":958100,"source":{"system":"sec-edgar","filing":"0001539937-26-000008","document":"wk-form4_1773691696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000008/wk-form4_1773691696.xml","form_type":"4"}},{"id":841302,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-16T20:08:19.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":10742,"price":51,"value":547842.0,"ownership":{"direct":false,"nature":"By the KBT Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.63 to $51.54. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":958220,"source":{"system":"sec-edgar","filing":"0001539937-26-000008","document":"wk-form4_1773691696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000008/wk-form4_1773691696.xml","form_type":"4"}},{"id":841301,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-16T20:08:19.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":24138,"price":50.09,"value":1209072.42,"ownership":{"direct":false,"nature":"By the KBT Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.63 to $50.62. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":968962,"source":{"system":"sec-edgar","filing":"0001539937-26-000008","document":"wk-form4_1773691696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000008/wk-form4_1773691696.xml","form_type":"4"}},{"id":841300,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-16T20:08:19.000Z","date":"2026-03-13","kind":"other","planned":true,"acquired":false,"shares":12500,"ownership":{"direct":false,"nature":"By the KBT Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person is filing this Form 4 to reflect the fact that 12,500 shares were transferred from the KBT Trust to the Reporting Person on March 13, 2026 without consideration and are now owned directly."}],"balance_after":993100,"source":{"system":"sec-edgar","filing":"0001539937-26-000008","document":"wk-form4_1773691696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000008/wk-form4_1773691696.xml","form_type":"4"}},{"id":841299,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-16T20:08:19.000Z","date":"2026-03-13","kind":"other","planned":true,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person is filing this Form 4 to reflect the fact that 12,500 shares were transferred from the KBT Trust to the Reporting Person on March 13, 2026 without consideration and are now owned directly."}],"balance_after":1241144,"source":{"system":"sec-edgar","filing":"0001539937-26-000008","document":"wk-form4_1773691696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000008/wk-form4_1773691696.xml","form_type":"4"}},{"id":841503,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-16T16:07:41.000Z","date":"2026-03-12","kind":"sale","planned":false,"acquired":false,"shares":5369,"price":50.61,"value":271725.09,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.45 to $50.82. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc., any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":60413,"source":{"system":"sec-edgar","filing":"0001438462-26-000006","document":"wk-form4_1773691657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000143846226000006/wk-form4_1773691657.xml","form_type":"4"}},{"id":850497,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2026-03-10T20:13:50.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":38640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":38640},"source":{"system":"sec-edgar","filing":"0001539937-26-000006","document":"wk-form4_1773173627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000006/wk-form4_1773173627.xml","form_type":"4"}},{"id":850496,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-10T20:13:50.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":16574,"price":54.73,"value":907095.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":1228644,"source":{"system":"sec-edgar","filing":"0001539937-26-000006","document":"wk-form4_1773173627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000006/wk-form4_1773173627.xml","form_type":"4"}},{"id":850495,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-10T20:13:50.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":38640,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1245218,"source":{"system":"sec-edgar","filing":"0001539937-26-000006","document":"wk-form4_1773173627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000006/wk-form4_1773173627.xml","form_type":"4"}},{"id":851102,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Performance Share Unit","published_at":"2026-03-10T20:13:22.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001804567-26-000010","document":"wk-form4_1773173598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000010/wk-form4_1773173598.xml","form_type":"4"}},{"id":851101,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-03-10T20:13:22.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":1623,"price":53.65,"value":87073.95,"ownership":{"direct":true},"balance_after":18440,"source":{"system":"sec-edgar","filing":"0001804567-26-000010","document":"wk-form4_1773173598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000010/wk-form4_1773173598.xml","form_type":"4"}},{"id":851100,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-03-10T20:13:22.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1793,"price":54.73,"value":98130.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":20063,"source":{"system":"sec-edgar","filing":"0001804567-26-000010","document":"wk-form4_1773173598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000010/wk-form4_1773173598.xml","form_type":"4"}},{"id":851099,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-03-10T20:13:22.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21856,"source":{"system":"sec-edgar","filing":"0001804567-26-000010","document":"wk-form4_1773173598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000010/wk-form4_1773173598.xml","form_type":"4"}},{"id":850661,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2026-03-10T20:12:53.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001194020-26-000010","document":"wk-form4_1773173570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000010/wk-form4_1773173570.xml","form_type":"4"}},{"id":850660,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2026-03-10T20:12:53.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001194020-26-000010","document":"wk-form4_1773173570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000010/wk-form4_1773173570.xml","form_type":"4"}},{"id":850659,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:53.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1450,"price":54.73,"value":79358.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":8232,"source":{"system":"sec-edgar","filing":"0001194020-26-000010","document":"wk-form4_1773173570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000010/wk-form4_1773173570.xml","form_type":"4"}},{"id":850658,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:53.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9682,"source":{"system":"sec-edgar","filing":"0001194020-26-000010","document":"wk-form4_1773173570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000010/wk-form4_1773173570.xml","form_type":"4"}},{"id":850657,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:53.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1433,"price":54.73,"value":78428.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":6682,"source":{"system":"sec-edgar","filing":"0001194020-26-000010","document":"wk-form4_1773173570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000010/wk-form4_1773173570.xml","form_type":"4"}},{"id":850656,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:53.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8115,"source":{"system":"sec-edgar","filing":"0001194020-26-000010","document":"wk-form4_1773173570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000010/wk-form4_1773173570.xml","form_type":"4"}},{"id":850494,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":61711,"kind":"person","name":"Horich William Todd","position":1,"cik":"0002117599","reported_name":"Horich William Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Performance Share Unit","published_at":"2026-03-10T20:12:10.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined\nperformance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined\nperformance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0002117599-26-000004","document":"wk-form4_1773173526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000211759926000004/wk-form4_1773173526.xml","form_type":"4"}},{"id":850493,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":61711,"kind":"person","name":"Horich William Todd","position":1,"cik":"0002117599","reported_name":"Horich William Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Performance Share Unit","published_at":"2026-03-10T20:12:10.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined\nperformance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined\nperformance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0002117599-26-000004","document":"wk-form4_1773173526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000211759926000004/wk-form4_1773173526.xml","form_type":"4"}},{"id":850492,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":61711,"kind":"person","name":"Horich William Todd","position":1,"cik":"0002117599","reported_name":"Horich William Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Performance Share Unit","published_at":"2026-03-10T20:12:10.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined\nperformance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined\nperformance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2625},"source":{"system":"sec-edgar","filing":"0002117599-26-000004","document":"wk-form4_1773173526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000211759926000004/wk-form4_1773173526.xml","form_type":"4"}},{"id":850491,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":61711,"kind":"person","name":"Horich William Todd","position":1,"cik":"0002117599","reported_name":"Horich William Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:10.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":4439,"price":55,"value":244145.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0002117599-26-000004","document":"wk-form4_1773173526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000211759926000004/wk-form4_1773173526.xml","form_type":"4"}},{"id":850490,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":61711,"kind":"person","name":"Horich William Todd","position":1,"cik":"0002117599","reported_name":"Horich William Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:10.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":4438,"price":54,"value":239652.0,"ownership":{"direct":true},"balance_after":4439,"source":{"system":"sec-edgar","filing":"0002117599-26-000004","document":"wk-form4_1773173526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000211759926000004/wk-form4_1773173526.xml","form_type":"4"}},{"id":850489,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":61711,"kind":"person","name":"Horich William Todd","position":1,"cik":"0002117599","reported_name":"Horich William Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:10.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":521,"price":54.73,"value":28514.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":8877,"source":{"system":"sec-edgar","filing":"0002117599-26-000004","document":"wk-form4_1773173526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000211759926000004/wk-form4_1773173526.xml","form_type":"4"}},{"id":850488,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":61711,"kind":"person","name":"Horich William Todd","position":1,"cik":"0002117599","reported_name":"Horich William Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:10.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9398,"source":{"system":"sec-edgar","filing":"0002117599-26-000004","document":"wk-form4_1773173526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000211759926000004/wk-form4_1773173526.xml","form_type":"4"}},{"id":850487,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":61711,"kind":"person","name":"Horich William Todd","position":1,"cik":"0002117599","reported_name":"Horich William Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:10.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1718,"price":54.73,"value":94026.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":8273,"source":{"system":"sec-edgar","filing":"0002117599-26-000004","document":"wk-form4_1773173526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000211759926000004/wk-form4_1773173526.xml","form_type":"4"}},{"id":850486,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":61711,"kind":"person","name":"Horich William Todd","position":1,"cik":"0002117599","reported_name":"Horich William Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:10.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9991,"source":{"system":"sec-edgar","filing":"0002117599-26-000004","document":"wk-form4_1773173526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000211759926000004/wk-form4_1773173526.xml","form_type":"4"}},{"id":850485,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":61711,"kind":"person","name":"Horich William Todd","position":1,"cik":"0002117599","reported_name":"Horich William Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:10.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1216,"price":54.73,"value":66551.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":6241,"source":{"system":"sec-edgar","filing":"0002117599-26-000004","document":"wk-form4_1773173526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000211759926000004/wk-form4_1773173526.xml","form_type":"4"}},{"id":850484,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":61711,"kind":"person","name":"Horich William Todd","position":1,"cik":"0002117599","reported_name":"Horich William Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Commercial Operations"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:10.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7457,"source":{"system":"sec-edgar","filing":"0002117599-26-000004","document":"wk-form4_1773173526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000211759926000004/wk-form4_1773173526.xml","form_type":"4"}},{"id":853268,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-03-09T20:06:53.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":7905,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":7905},"source":{"system":"sec-edgar","filing":"0001256088-26-000006","document":"wk-form4_1773086807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000006/wk-form4_1773086807.xml","form_type":"4"}},{"id":853267,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:06:53.000Z","date":"2026-03-06","kind":"sale","planned":false,"acquired":false,"shares":8787,"price":53,"value":465711.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.03. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":27277,"source":{"system":"sec-edgar","filing":"0001256088-26-000006","document":"wk-form4_1773086807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000006/wk-form4_1773086807.xml","form_type":"4"}},{"id":853266,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:06:53.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":7905,"price":25.3,"value":199996.5,"ownership":{"direct":true},"balance_after":36064,"source":{"system":"sec-edgar","filing":"0001256088-26-000006","document":"wk-form4_1773086807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000006/wk-form4_1773086807.xml","form_type":"4"}},{"id":853265,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:06:53.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":53.71,"value":537100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.50 to $54.15. The Reporting Person undertakes to provide to\nSupernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold\nat each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":28159,"source":{"system":"sec-edgar","filing":"0001256088-26-000006","document":"wk-form4_1773086807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000006/wk-form4_1773086807.xml","form_type":"4"}},{"id":865761,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2026-03-03T21:12:06.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":38640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":38640,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":38640},"source":{"system":"sec-edgar","filing":"0001539937-26-000004","document":"wk-form4_1772572321.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000004/wk-form4_1772572321.xml","form_type":"4"}},{"id":865940,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2026-03-03T21:11:16.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":3000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001194020-26-000008","document":"wk-form4_1772572265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000008/wk-form4_1772572265.xml","form_type":"4"}},{"id":865939,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2026-03-03T21:11:16.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":3000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001194020-26-000008","document":"wk-form4_1772572265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000008/wk-form4_1772572265.xml","form_type":"4"}},{"id":867783,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Performance Share Unit","published_at":"2026-03-03T21:09:51.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."}],"balance_after":3750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001804567-26-000008","document":"wk-form4_1772572184.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000008/wk-form4_1772572184.xml","form_type":"4"}},{"id":879791,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-26T21:19:59.000Z","date":"2026-02-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":1875,"derivative":{"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001804567-26-000006","document":"wk-form4_1772140796.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000006/wk-form4_1772140796.xml","form_type":"4"}},{"id":879790,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:19:59.000Z","date":"2026-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":977,"price":50.69,"value":49524.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":18106,"source":{"system":"sec-edgar","filing":"0001804567-26-000006","document":"wk-form4_1772140796.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000006/wk-form4_1772140796.xml","form_type":"4"}},{"id":879789,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23368,"kind":"person","name":"Mottola Frank","position":1,"cik":"0001804567","reported_name":"Mottola Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Tech. Ops. Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:19:59.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19083,"source":{"system":"sec-edgar","filing":"0001804567-26-000006","document":"wk-form4_1772140796.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804567/000180456726000006/wk-form4_1772140796.xml","form_type":"4"}},{"id":879387,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-26T21:19:19.000Z","date":"2026-02-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":2500,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001194020-26-000006","document":"wk-form4_1772140756.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000006/wk-form4_1772140756.xml","form_type":"4"}},{"id":879386,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-26T21:19:19.000Z","date":"2026-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1279,"price":50.69,"value":64832.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":5115,"source":{"system":"sec-edgar","filing":"0001194020-26-000006","document":"wk-form4_1772140756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000006/wk-form4_1772140756.xml","form_type":"4"}},{"id":879385,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-26T21:19:19.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6394,"source":{"system":"sec-edgar","filing":"0001194020-26-000006","document":"wk-form4_1772140756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000006/wk-form4_1772140756.xml","form_type":"4"}},{"id":879366,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-26T21:18:23.000Z","date":"2026-02-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":1250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001539215-26-000006","document":"wk-form4_1772140700.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000006/wk-form4_1772140700.xml","form_type":"4"}},{"id":879365,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-02-26T21:18:23.000Z","date":"2026-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":650,"price":50.69,"value":32948.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":17044,"source":{"system":"sec-edgar","filing":"0001539215-26-000006","document":"wk-form4_1772140700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000006/wk-form4_1772140700.xml","form_type":"4"}},{"id":879364,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23271,"kind":"person","name":"Bhatt Padmanabh P.","position":1,"cik":"0001539215","reported_name":"Bhatt Padmanabh P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of IP, CSO"}}],"security":"Common Stock","published_at":"2026-02-26T21:18:23.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17694,"source":{"system":"sec-edgar","filing":"0001539215-26-000006","document":"wk-form4_1772140700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153921526000006/wk-form4_1772140700.xml","form_type":"4"}},{"id":879816,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-26T21:17:42.000Z","date":"2026-02-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":1250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001836067-26-000006","document":"wk-form4_1772140659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000006/wk-form4_1772140659.xml","form_type":"4"}},{"id":879815,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:17:42.000Z","date":"2026-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":675,"price":50.69,"value":34215.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":13341,"source":{"system":"sec-edgar","filing":"0001836067-26-000006","document":"wk-form4_1772140659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000006/wk-form4_1772140659.xml","form_type":"4"}},{"id":879814,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:17:42.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14016,"source":{"system":"sec-edgar","filing":"0001836067-26-000006","document":"wk-form4_1772140659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000006/wk-form4_1772140659.xml","form_type":"4"}},{"id":881710,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881709,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881708,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."}],"balance_after":3375,"derivative":{"underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881707,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1524,"price":50.86,"value":77510.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":3894,"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881706,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5418,"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881705,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":242,"price":50.86,"value":12308.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":2418,"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881704,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2660,"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881703,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":603,"price":51.35,"value":30964.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":2160,"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}}],"next_cursor":"2026-02-25T22:22:00.000000Z,881703"}